Price movement over the last 24 hours
Alcon AG vs PepsiCo, Inc. — how do they compare? Alcon AG trades at $66.87 (market cap $32.69B), while PepsiCo, Inc. trades at $143.89 (market cap $198.15B). The key difference: PepsiCo, Inc. is far larger — about 6.1× Alcon AG's market cap, and PepsiCo, Inc. pays the higher dividend (4.08%). Which is the better fit depends on your goals.
| ALC | PEP | |
|---|---|---|
Market Cap | $32.69B | $198.15B |
Sector | Health | Consumer Staples |
52-Week High | $92.22 | $170.44 |
52-Week Low | $62.02 | $133.81 |
Enterprise Value | $36.28B | $240.05B |
Dividend Yield | 0.54% | 4.08% |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
PepsiCo (PEP) trades at $144.6, up 0.91% on the day, with a bullish technical signal and recent earnings beats. The stock shows strong profitability with a 9.15% net margin and 43.92% ROE, though revenue growth remains modest at 2.2% year-over-year. Recent news highlights price cuts on snacks after consumer pushback on high prices, while the company prepares for Q1 2026 earnings next week.
The outlook is cautiously optimistic with a consensus price target of $161.73 (12% upside). Analyst sentiment leans neutral (63.64% Hold), balancing strong cash flow and brand power against pricing pressures and modest growth. Key risks include execution of North America turnaround and consumer sensitivity to price hikes.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →